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Sammendrag:
Datte dokument er en rappqrt fra det 3 ~ nordiske møtet for
utvikling av scre.eaing...metoder fqr bestemmelse av individuell
eksponering for mutagene og krefttranka~lende stoffe~. Nordisk
Ministerråd har gitt finansi.ell støtte til prosjektet. I de
nordißke land pågar et aktivt: forskningsarbeid innen biologisk
monitorering . Det er opprettet en arbeiClsgl:uppe med deltagere
som repr~senterer ulike forskningsinstitutter i de nordiske land.
Gruppen har medlemmer fra Danmark, Finland, porge og Sverige, 3
medlemmer fra hvert land. Arbeidsgruppen inøtès årlig. I gruppens
arbeidsoppgaver inngår:
- kartlegge det aktuelle kunnskapsnivå og forskningsbehov
- koordinere våre prosjekter hvor ulike metoder anvendes
- harmonisere metodene
- foreslå problemstill:Lnge~og forskningspr6sjekter ved
egne eller andre institutter
Stikkord: No:ißisk samarbeid
Mu tagener
Kreftframkallende stoffer
Biomoni tore ring
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OF INDIVIDUAL EXPOSURE TO MUTAGENS AND
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41. OPPSUMMERING
Onsdag 03.10. - fredag 05.10.90 møttes arbeidsgruppen i Finland. Møtet ble
avholdt på Hotel Seurahovi i Porvoo med 21 deltagere. Hovedemnene denne gang
var nye metoder i biologisk monitorering og genetisk predisposisjon. I den
forbindelse var det invitert to eksterne foredragsholdere, Jeffrey R. ldle og
Peter Farmer fra U K. De holdt følgende forelesninger:
P. Farmer: New and alternative methods in biological monitoring.
J. Idle: Interindividual variation in carcinogenesis.
Deretter orienterte deltagerne om forskningsprosjektene. Både foredragene og
diskusjonene fungerte meget bra. Mange emner og problemstilinger innen
biologisk monitorering ble tatt opp og flere samarbeidsprosjekter er under
utvikling både innen gruppen og med andre forskningsgrupper. Avslutningsmøtet
for dette prosjektet arrangeres i Norge om ett år og det skal skrives en
sluttrapport.
Medlemmene av prosjektets styringsgruppe er:
Aage Haugen, Statens arbeidsmiljøinstitutt, Oslo. (Ansvarlig leder av prosjektet).
Herman Autrup, Institutt for Miljø og Arbejdsmedicin, Ârhus.
Kari Hemminki, Institutt for Arbeidshygiene, Helsinki.
Christer Hogstedt, Arbeidsmiljøinstituttet, Solna.
Oslo, 1. februar 1991
Aage Haugen
WORKSHOP ON INTERINDIVIDUAL VARIATION IN
CARCINOGENSIS
Chairman: H. Autrup14.15-15.15 Keynote leeture
J. Idle. Interindividual variation in
carcinogenesis
Discussion
Coffee Break
K. Vähäkangas. Different approaches to
study interindividual and organ variation
in human PAH-inducible P450 activities
A. Haugen. Rare Ha-ras-l alleles and
susceptibili ty to human lung cancer
Discussion
Breakfast
WORKSHOP ON NEW AN ALTERNATIVE METHODS IN
BIOLOGICAL MONITORING
Chairman: A. Haugen
9.00-10.00 Keynote leeture
P.B. Farmer. New and alternative methods
in biological moni toring
Discussion
Coffee break
K. Husgafvel-Pursiainen. Detection of K-
ras mutations in lung carcinoma by
oligonucleotide hybridization and DGGEA. Önfelt.
A.L. Børresen. Mutation analysis in human
cancers using CDGE
Discussion
2. PROGRA
Wednesdav 03.10.90
13.00-14.00
14.00-14.15
1 4 . 15-1 7 . 1 5
15.15-15.30
15.30-15.45
15.45-16.15
16.15-16.45
1 6.45-1 7 . 1 5
18.00
Thursdav 04.10.90
9.00-12.30
10.00-10.15
10.15-10.30
10.30-11.00
11.00-11.30
11.30-12.00
12.00-12.30
12.30-14.00
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Arri val
Lunch
Welcome, K. Hemminki
Dinner.
Lunch
1 4 . O O -1 8 . O O WORKSHOP ON MEASURES OF PRODUCTS OF EXPOSURE
Chairman: K. Hemminki14.00-14.30 R. Mustonen. Analysis of 7-guanine
methylated DNA by postlabeling
14.30-15.00 C. Hansen. Detection of carcinogen-DNA
adducts by 32-p postlabeling
15.00-15.30
15.30-15.45
15.45-16.00
16.00-16.30
16.30-17.00
17.00-17.30
17.30-18.00
18.00-18.15
18.30
Fridav 05.10.90
9.00-9.30
9.30-10.00
1 O . O O - /1 O . 1 5
10.15-12.00
12.00-13.00
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K. Hemminki. Quantitative aspects of 32-p
postlabeling
D. Segerbäck. Planned and ongoing
activities at the center for Nutrition and
Toxicology, Karolinska Institute
Coffee break
S. Øvrebø. PAH adducts levels in WBC
compared to industrial exposure
K. Vähäkangas. Current status of the Raahe
coke oven study
H. Autrup. Exposure to aflatoxin B in
Danish animal feed production workers
M. Törnqvist. Hemoglobin adducts:
usefulness for identification and
quantification of chemical risks
Discussion
Dinner
Breakfast
M. Sorsa. Prediction of cancer risk by
cytogenetics.
K. Wassermann. Genotoxicology at the Danish
National Institute of Occupational Health
Coffee break
Interlaboratory collaboration
Lunch
Departure
73. ABSTRACTS
8DIFFERENT APPROACHE TO srUDY INTERIDMDUAL AND ORGAN VARTION
IN HUMA PAH-INDUCIBLE P450 ACTMTIF.
Kirsi Vähäkangas, Markku Pasanen, Hannu Raunio and Olavi Pelkonen, Department of
Pharmacology and Toxicology, University of Oulu, Oulu, Finland.
It is not known to which extent the variation in the patterns and/or activities of P450
isozymes are responsible for the varying susceptibilties of different organs and
individuals to e.g. chemical carcinogens. We are trying to find the best markers for
relevant isozyme activities to correlate these in the future to the disease proeess. We
have found for instanee that AHH activity does not correlate with the formation of
BPDE-DNA adducts in human placental microsomes or cultured blood lymphocytes.
Since the adduct-formation is in association with the carcinogenicity of benzo(a)pyrene,
it ffay be a more relevant measure than the AHl--activity which measures the
formation of hydroxy metabolites. Isozyme-specific inhibitors or panels of inhibitors
have proved useful in characterizing the human isozymes behind the enzyme activities.
Using this approach we have shown that isozymes of P450 responsible for debrisoquine
hydroxylation or some other activities do not contribute significantly to hepatic or
placental AHH and ERDE activities. We also use monoclonal antibodies towards
different isozymes of P450 to map isozyme paterns in human tissues. Unfortunately the
availabilty of specific antibodies is rather restricted. Also, they differ greatly in their
usabilty in inhibition and immunoblotting studies. Monoclonal antibody Mab 1-7-1,
which has been raised towards the PAH-inducible P450 in rat liver by Park, Gelboin and
co-workers, inhibits several activities in human placental microsomes, but does not
detect any protein in Western blots. With this same antibody we have found large
interindividual differences in the inhibition of activities when comparing different
tissues and individuals.
9New and al ternati ve methods in biological moni tor ing
P.B.Farmer, MRC Toxicology Unit, Medical Research Council
Laborator ies, Woodmansterne Road, Ca r shal ton, Sur rey SMS 4EF,
U. K.
Over the past L S years, biological moni tor ing techniques have
been developed to quantify the exposure of man to genotoxic agents
by measurement of the covalent adducts that these agents form
wi th nucleic acid bases and amino acids in haemoglobin.
Sensitivities in excess of those required to detect
environmental exposure are now achievable for several
electrophilic genotoxins. These methods, and the latest
analytical developments will be reviewed cri tically. Examples
of recently developed assays from our laboratory for determining
exposure to styrene oxide and. aromatic amines (e.g.
4,4' -methylene dianiline, 4,4' -methylene bis (2-chloroaniline))
will be illustrated and the problems that arise from the
existence of 'background leveIs' of adducts described.
The detection of a protein adduct is now recognised to
indicate the presence of a DNA adduct al though the quanti tati ve
relationship varies from compound to compound. However the value
of protein adduct measurements as an indication of genotoxic risk
is st ill somewhat uncertain for human populations. It is hoped
that cur rent inter laboratory compar i sons of moni tor ing techniques
for DNA and protein adducts and of selected genetic end points
will clarify this important relationship.
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Detection of K-ras mutations in lung carcinoma by
oligonucleotide hybridization and denaturing gradient gel
electrophoresis (DGGE)
Kirsti Husgafvel-Pursiainen
Insti tute of Occupational Heal th, Helsinki, Finland
Point mutational activation of K-ras oncogene has been
implicated to play an important role in the pathogenesis of
non-small-cell lung cancer. We have studied the prevalence of
point mutations in c-K-ras-2 in lung carcinoma. Genomic DNA
was extracted from lung tumor biopsy samples and peripheral
whi te blood cells obtained from 36 lung cancer patients be fore
any treatment. The particular DNA sequences under study were
amplified enzymatically, dot blotted and analyzed for
activating point mutations in K-ras codons 12, 13 and 61 by
hybridization wi th specific oligonucleotide probes . The 36
lung carcinomas under study included 17 squamous-cell
carcinomas, 16 adenocarcinomas and 3 small-cell carcinomas.
Al together , 13 cases wi th point mutations in K-ras oncogene
were found by oligonucleotide hybridization analysis. Codon 12
mutations were observed to be predominant in adenocarcinomas,
only one adenocarcinoma case wi th codon 1 3 and one wi th codon
61 mutation was observed. Of the three squamous-cell
carcinomas showing mutations, two had codon 12 mutations and
one a codon 13 mutation. The white blood cell DNAs were all
negative for point mutations in K-ras. We also applied
denaturing gradient gel electrophoresis (DGGE) in analyzing
the material. By this promising new technique were able to
detect most of the mutations found by oligonucleotide
hybridization analysis but not all of them. Furthermore, we
were able to find an addi tional new mutation in the exon 1
region, since this technique is not limited to the previously
known mutations of interest as is the case wi th the
oligonucleotide probing .
Part of this work is done in collaboration with Børresen et al. (The Norwegian Radium Hospital, Oslo)
and financially supported by the Nordie Industrial Fund.
o
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ABSTRACT
Activities at the National Institute of Occupational Health, Dpt
Occupational Medicine, Solna, Sweden
Agneta Önfelt
Our work i s di vi ded i nto three mai ri areas:
1. C!Jtogenetic studies of occupatioriall!J exposed groups and in vitro
genotoxicit!J tests of chemical or ph!Jsical agents.
2. Basic research on mitosis and mechanisms for induction of aneuploidy.
3. r101ecular analysis of point mutations and establishment of conventional
mo 1 ecul ar techni ques for eva 1 uat i on of gene expressi on.
In collaboration with Benkt Högstedt, Halmstad hospital, we are presentl!d
investigating micronucleus formation in lymphocytes in samples from
chirnne!d sweeps. Within this stud!J we compare two different protocols,
''Nith and without addit i on of c!Jtocha 1 asi n B respect i ve 1 y.
The projects concerning rnitosis represent the major part of our 'work at
present. Vie are parti cul arl y i nterested i n secondary si gna L systems and
the possible role of primar!d signals. For the latter part we have found
strong indications on the involvernent of acet!Jlcholin and its various
receptors. The work with analytical methods for detection and
characterization of point rnutations is part of the inter-Nordie
eollaboration fineinced by Nordisk Industrifond. 50 far we have focused on
the N-ras and HPRT loei utilising dot blotting, peR and DGGE (see
Børresen).
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ILL NORDIC STUDY GROUP MEETING.
Helsinki 3-5 Öctober 1990
MUTATION ANALYSI~ IN HUMAN CANCERS USING PCR AND CONSTANT DENATURING
GEL ELECTROPHORESIS (CDGE). A .-L. BØrresen, E. Hovig, B.
Smith-Sørensen, S. Lystad and A. Brøgger. Dept. of Genetics, Inst. for
Cancer Research, The Norwegian Radium Hospital, 0310 Oslo 3, Norway.
Detection and localization of single base differences in specific
regions of genomic DNA are of great importanee in analysis of mutations
associated with human diseases . Both inh~rited and aquired mutations
are of importanee in analysis of malignant diseases . Denaturing
gradien t gels have the poten tial of revealing min or base changes in
DNA. Coupled wi th PCR, this system represents a powerful tool in
detection of mutations. The basis for this electrophoretic separation
technique is strand dissociation of DNA fragments in discrete, sequence
dependen t mel ting domains followed by an abrupt decrease in mobili ty.
We have modified the DGGE by using constant denaturant gels
corresponding to the specific melting domains of certain DNA fragments.This leads to increased resolution of mutants asfragments differing in
as li ttle as one base pair migrate wi th a consistently different
mobility through the whole gel allowing separations ofseveral
centimeters . We have also utilized a mini~gel-system for running these
gels, effecti vely reducing running times, wi thout losing resolution. As
a model system we have used this technique to separate six out of seven
exon 3 hypoxanthine phosphoribosyl transferase (HPRT) presequenced
mutants, while using conventional DGGE we were able to separate three.
We have now introduced this system to screen for mutations wi thin the
Rb gene and the p53 gene in different human cancers. The system seems
to be rapid and reliable in screening for mutations in human cancers.
DETECTION OF CARCIHOGEH-DHA ADDUCTS BY 32-P POSTLELING
. 13
Hansen, C., Autrup, H.
Department of Environmental Carcinogenesis, The Fibiger Insti-
tute, Ndr. Frihavnsgade 70, DK-2100 Copenhagen
Carcinogen-DNA adducts are believed to be directly involved in
the steps of ini tiation and malignant progression in carcino-
genesis. We have investigated if carcinogen-DNA adducts could be
detected and correlated to smoking or occupational exposure to
styrene using 32-P postlabeling .
The influence of maternal smoking during pregnancy on adduct
levels in placenta and umbilical cord vein and artery was in-
vestigated. Samples of placenta and umbilical cord were obtained
from 20 women, 12 non-smokers and 8 smokers, giving birth to nor-
mal heal thy children and adduct levels in the three tissues were
compared. It was found that mean adduct levels in the three tis-
sues were unlike, with placenta and umbilical cord artery at the
same level, while the mean level in the vein were significantly
lower, indicating a transplacental exposure to the fetus and that
the higher mean adduct level in artery could be due to fetal me-
tabolism of procarcinogens. A difference between mean adduct
levels in the three tissues investigated was observed when the
tissues were compared wi th respect to smoking behaviour. This
difference, although not statistically significant using non-
parametric statistics, showed that smokers mean adduct levels
were higher in all three tissues as compared to mean levels in
non-smokers.
We have investigated if other tissues, different from those
normally utilizeed in human exposure studies could be of use in
postlabeling studies. For this purpose , samples of human sperm
DNA obtained from a group of smokers and non-smokers, was
analyzed. However no correlation between adduct levels and
smoking status was' observed.
styrene, a widely used compound in the reinforced plastics indu-
stry and in the production of polystyrene, is metabolized to the
ul timate carcinogen, styrene-7, 8-oxide, that has been shown to
induce SCEs in humans as well as cancer in rats. Due to these ob-
servations it is suspected that styrene may consti tute a poten-
tial occupational hazard. The aims of this part of our studies
has been to develop methodologies to detect and quantitate ad-
ducts formed between DNA and the ul timate carcinogenic form of
styrene. So far we have focused on calf thymus DNA reacted in
vi tro wi th styrene-7 , 8-oxide, and used the postlabeling technique
to detect and quantitate the adducts formed in order to establish
the proper experimental conditions for maximal sensitivity of the
technique. It has been possible to detect and quanti tate 5 ad-
ducts wi th dose-response properties. In experiments where mice
were gi ven a single intragastric dose (0.01 to 10 mg/kg) no
styrene related adducts have so far been detected in liver, colon
or kidney DNA. Since it is assumed that the N7-guanine adduct of
styrene-Ç)xide is unstable, an animal system, in which urine
obtained from rats treated wi th radiolabeled guanine and
styreneoxide were collected. These preliminary data show that a
double-Iabeled fraction can be isolated after elution through C-
ia Seppak and HPLC suggesting that this could be repair products
of N7-guanine and styreneoxide.
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;\t QUANTITATIVE ASPECTS OF 32p-POSTLABELING
~
;1
?
Kari Hemminki. Krzysztof Szyfter. Pavel Vodicka. Pertti Koi visto.
Rii tta Mustonen and Anne Reunanen
Institute of Occupational Health. Topeliuksenkatu 41 a A.
00250 Helsinki. FINLAND
Summa ry 
'l
d 32 .Two parameters of the P-postlabeling assay were evaluated
using 19 synthesized adduct standards. some wi th two diastereomeric
forms. One parameter was the efficiency of label ing. i. e. the
proportion of the adduct added phosphorylated by T 4 pOlynucleotide
kinase. While some adducts labeled well. low labeling was noted for
N-7 guanine adducts. in particular. The reasons were likely to be
steric. The other parameter scrutinized was 3' -dephosphorylation by
nuclease Pl. a technique used to enrich the adducts before
postlabeling . Usually. bulky adducts were resistant towards
dephosphorylation.t
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PAH adduct levels in WBC compared to industrial PAR exposure.
s. Øvrebø, A. Haugen, H. Barstad and P. E. Fjeldstad
National Institute of Occupational Health, POB 8149 Dep,
N-0033 Oslo 1, Norway.
Exposure to polycyclic aromatie hydrocarbons (PAH) is found in
several different industries. Best known are coke oven plants,
aluminum plants, foundry works, electrode production and gas
works. The level of PAH exposure is highly variable both wi th
respect to job categories and industry type.
Literature data shows that benzo(a)pyrene concentrations
in air vary considerably in different factories wi th PAH
exposure, but is typically highest in coke oven plants,
aluminum plants and among roofers. We have recently studied
exposure in an aluminum plant and an electrode factory were
the levels of benzo(a)pyrene (B(a)P) exposure was medium.
Based on li terature data the re is no consistent relation
between B(a)P exposure and adduct levels in industri al
exposure to PAH, for example in aluminum plants high levels of
exposure is found but few adduct level determination have be en
reported. However in foundry works relati vely high adduct
levels have been published al though low air values are found.
Relations between air measurements of PAH and adduct
levels will be discussed based on li terature data and our own
measurements.
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CURRNT SlATUS OF THE RA COKE OVE PLAT SlUDY
Kirsi Vahakangasi, Olavi Pelkoneni, Steinar Øvrebø2, Aage Haugen2, Anne Reunanen3,
Anneli Alhonen-Raatesalmi3, Kari Hemminki3, Lauri pyy4, Erkki Yrjanheikki4.
Department of Pharmacology and Toxicology, University of Oulu' and Regional
Institute of Occupational Health, Oulu, Finland4; Institute of Occupational Health,
Helsinki, Finland3; Department of Toxicology, National Institute of Occupational
Health, Oslo, Norway2.
A coke oven plant started its function in Raahe, Finland in October 1987. Samples for
biomonitoring were taken from September 1987 on. This way we are able to follow
individually, whether and how much the available biodosimetry methods reflect the
change from a non-exposure situation to an occupational exposure. We have taken four
sets of samples, which are referred to as A(before exposure), B(6 months after the
start), c(1,5 years) and °(2,5 years). Each time stationary and personal air samples have
been collected, as well as blood and urine samples from the workers. They have also
filed a questionnaire about e.g. smoking habits. Several parameters of potential value
for biomonitoring of PAH-exposure are being studied, including 1-0H-pyrene in urine
and PAH-DNA adducts in blood lymphocyte DNA.
The major PAH-compounds in the air were phenanthrene, pyrene, chrysene,
benzo(a)pyrene and benzo(e)pyrene. Naphtalene was found to be the main compound in
the gasous samples. The highest air levels were measured on top and on the sides of
the coke oven. There was a significant correlation between the pyrene concentrations
in the air and the urinary 1-0H-pyrene leveIs. BPDE-DNA adducts in peripheral blood
lymphocytes are being measured by three different methods:
Synchronous fluorescenee spectrophotometry (SFS), USERIA immunoassay and
32p-postlabeling. According to the samples measured so far, the adduct levels have been
very low or undetectable for the most part. We have found no difference between the
smokers and non-smokers in the adduct levels either by SFS or USERIA in sets A and
B. The mean fluorescenee value was highest in set B, lower in set C (only partly
analyzed) and lowest in set A. Set D is being analyzed. By USERIA there were a couple
of more values over 0.8 fmol/)Jg in set B (11 %) than in set A (5,5%). By 32p-postlabeIing
there seem to be higher levels of adducts in the samples from set C than from A and
B. The results are being analyzed currently.
On basis of these findings it can already be concluded that smokers can not be
differentiated from non-smokers by the means of the PAH-DNA adducts in lymphocyte
DNA. At this point it seems that the urinary 1-0H-pyrine and/or detection of
carcinogen-DNA adducts in peripheral blood lymphocyte DNA may have value as
biomonitoring methods in workers occupationally exposed to P AH.
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Exposure to Afatoxin B in Danish Animal Fee.d Produetion Workers.
Autrupj Jj Schmidt J., Serernet, T. and Autrup, H.
\Vorkers in animal feed production have an increased risk of dcvcloping live r cancer,
and it is assumed that aflatoxin B (AFB) play an important role as a causative agent.
A competitive ELI$A assay has been developed using a monoclonal antibody that
recognizes APB. The albumin fraction is Isolated from blood Serum by.precipitatîol1
and is digested with pronase (0.67 mg/l mg albumin) for 18 hrs. at 37°, The digest
is purified on a Ci8 suppla column, and the AFB-containing fraction is eluted by 80%
methanol. This fraction is concentrated on an Afatest affinity colun'in, and eluted by
50% methano1. TIie cantent of aflatoxin was determIned by a competetive ELISA.
The sensitivity of the assays is 5 og AFB/mg albumin. The level of detectability can
be Increased by increasing the amount of albumin uscd for digestion.
Blood sample have been collected from 35 workers, working at 3 different sites after
their return from 4 weeks of vacation, and samples after 2 manths at work in the
plants wiIl be collected early October.
18
HEMOGLOBIN ADDUCTS: USEFULNESS FOR IDENTIFICATION AND QUANTIFICATION OF
CHEMICAL CANCER RISKS
Margareta Törnqvist. Department of Radiobiology. Stockholm University.
S-106 91 STOCKHOLM. SWEDEN
Determination of hemoglobin adducts in human populations give an adequate
measure of dose. because of the well-defined life-spun of the red cells.
This technique solves most of the problems involved in risk assessment on
the basis of disease-epidemiological data or experimental data with
observations of biological end-points:
Sensitivity is sufficient for the detection of risks down to the level
where risks are becoming acceptably low.
- Measurement can be done shortly after onset of exposure. i. e. the long
latency times are overcome.
- The causative agent is identified.
- Adduct levels measured are useful for risk quantification.
- The need for animal experiments is restricted to short-term tests with
a few individuals for dose-distribution studies etc.
This will be exemplified with studies on epoxides and alkenes under
various exposure conditions and developments of analytical techniques
will be discussed.
":"l'l" ~ j' ;;i:I,L I ....
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Genotoxicology at The Danish National Institute of
Occupational Health. Current and future activities.
Karsten Wassermann i Bjørn A. Nax0, Lisbeth Knudsen and Mona~
Lise Binderup, Section of Blotechnology and Genotoxicology,
Laboratory of Biology and Toxlcology, The Danish National Institute
of Oceupational Health, Copenhagen, Danmark.
The section of biotechnology and genotoxicology is In the proeess
of establishing commonly accepted genotoxic and cytogenetic
tests in our newly build laboratories. These tests, among which are
unscheduled DNA synthesis (UDS), the mlcronucleus test, Amas'
test, and yeast assay, wlU serve as a basis for environmental and
blological monitoring. Typlcally, Amas' test is suitable for
measurements of point mutations, whereas the use of S. Cerevisla6
D7 and 061 M also may be applicable for studles of recombination
and aneuploldy induction. A study of cytogenetíc monitoring
including analysls of chromosomal Integrity and overall DNA repaìr
in Iymphocytes from a population of stainIess stael welders has
now been concluded; the study showed a.a.t. an increased
frequency of chromosomal aberratlons and a decrease in UDS
upon exposura to stainless welding. A validatton of the molecular
aspects of Na-AAF induced UDS, which was used as a measure of
overall DNA repair in the total population of Iymphocytes, is now
belng pursued. Thus, studies of chemical-DNA adduct formation
and repair at the level of the gane in the context of heterogeneous
DNA damage and repair wil be performed. Here we have al ready
developed suitable techniques for the analysis of alkylatlon
dam age and repair in speclflc genomic reglons from cells in
culture. FInally, the section is In the proeess of developlng a
ratrovirus-based mutagenicíty assay for In vìvo studies. Thls new
test is based on an endogenous provirus, Emv.3, in the DBN2
mouse, which has an inharent point mutatlon in eodon 3 of the
gag-gene. Young animals do not have replicating virus, which,
however, may be stlmulated upon exposure to e.g. 7,12.
dlmethylbenzanthracene (DMBA). This stimulation may be
measured as an increase of a specific gene product shortly after
9xposure.
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